🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts stated the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or administering at home.

Within minutes of joining one group, a seller posted contact information, where most purchases take place. The seller sent an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Information and Costs

Within these groups, messages display black plastic parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject patients to possibly serious medical dangers”.